Clinical trial
Allogeneic Cell Therapy for Adults With Hematologic Malignancies
NCT00208962 is registered in ClinicalTrials.gov with Emory University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Allogeneic Cell Therapy for Adults With Hematologic Malignancies
- Lead sponsor
- Emory University
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- September 30, 1998
- Completion date
- August 31, 2013
- Enrollment
- 32 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.